Home / Sweden / Ascelia Pharma AB
Ascelia Pharma AB
No short position is open on this share today.
0.00% of the capital sold short
0 disclosing funds
18 disclosures on record
Evolution of the disclosed total
0%0.2%0.4%0.6%0.8%
Jan 2026Apr 2026Jul 2026Oct 2026
March 18, 2021 today
Open positions
No fund discloses a short position on this share today. The History of disclosures table lists the ones that existed.
Get the moves on Ascelia Pharma AB by mail, at most once a day.
There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| August 19, 2026 | Citadel Securities (Europe) Limited | 0.65% | |
| August 18, 2026 | Citadel Securities (Europe) Limited | 0.54% | |
| July 23, 2026 | Citadel Securities (Europe) Limited | 0.73% | |
| July 22, 2026 | Citadel Securities (Europe) Limited | 0.68% | |
| July 16, 2026 | Citadel Securities (Europe) Limited | 0.73% | |
| July 15, 2026 | Citadel Securities (Europe) Limited | 0.57% | |
| July 13, 2026 | Citadel Securities (Europe) Limited | 0.79% | |
| July 10, 2026 | Citadel Securities (Europe) Limited | 0.68% | |
| July 6, 2026 | Citadel Securities (Europe) Limited | 0.79% | |
| September 18, 2024 | Guevoura Fund | 0.80% | |
| September 13, 2024 | Guevoura Fund | 0.78% | |
| September 11, 2024 | Guevoura Fund | 0.60% | |
| September 10, 2024 | Guevoura Fund | 1.36% | |
| September 9, 2024 | Guevoura Fund | 0.92% | |
| August 29, 2024 | Quartys Limited | 0.51% | |
| March 23, 2021 | Celina Fondförvaltning AB | 0.62% | |
| March 22, 2021 | Celina Fondförvaltning AB | 0.72% | |
| March 18, 2021 | Celina Fondförvaltning AB | 0.87% |
Download 18 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats
Other companies sold short in Sweden
- Samhällsbyggnadsbolaget i Norden AB 11.12% of the capital sold short
- JM AB 7.91% of the capital sold short
- Elekta AB (publ) 7.77% of the capital sold short
- Truecaller AB 6.67% of the capital sold short
- Intrum AB 6.12% of the capital sold short
- RaySearch Laboratories AB (publ) 5.38% of the capital sold short
- Xvivo Perfusion Aktiebolag 5.15% of the capital sold short
- Cibus Real Estate AB (publ) 4.78% of the capital sold short
- Hemnet Group AB (publ) 4.73% of the capital sold short
- Mips AB 4.64% of the capital sold short
- Aktiebolaget Electrolux 4.12% of the capital sold short
- Castellum Aktiebolag 3.93% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Ascelia Pharma AB, source Finansinspektionen, data as at August 19, 2026, https://www.quivad.com/action/ascelia-pharma-ab